Expanding Your Keratoplasty Repertoire
A round-up of the most recent innovations in corneal transplantation.
Featured Content
Dry Eye
Getting to the Root of Dry Eye
Determining the cause of dry-eye signs and symptoms can be challenging. Surgeons share tips and pearls.
Dry Eye
Approaches and Methods for Treating Dry Eye: 2021
As the population of dry eye patients continues to grow, so do the available options for intervention.
Retina
Why Surgeons Are Peeling Fewer ERMs
Watchful waiting is now often putting this procedure on hold. Veteran vitreoretinal surgeons explain what’s critical for you to know.
Review of Ophthalmology Online eNewsletter
In this Issue:
Blood Pressure & Glaucomatous Progression
Did lower mean arterial and diastolic arterial pressure correlate with RNFL loss?
Systemic Health and Medication Use Impact on GA Growth Rate in AMD
See which factors may be associated with the growth rate.
Long-term Changes in the Refractive Effect of a Toric IOL on Astigmatism Correction
Learn what factors caused deterioration of effect of the lenses.
Inhibition of Complement C3 in GA with NGM621
Find out if NGM621 was safe and tolerable when administered intravitreally up to 15 mg.
Industry News
Continuing Medical Education
-
A Closer Look: Emerging Medical Therapies for Presbyopia
This CME activity provides an overview of age-related loss of accommodation as well as several of the emerging topical therapies for presbyopia that are under investigation. Perspectives on selection of prospective patients as well as potential opportunities for practice growth are also discussed. -
Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat
A panel of experts discuss the importance of early detection of neurotrophic keratitis and the latest data on available treatment options in this CME activity. -
Breaking New Ground: Reducing Treatment Burden in Neovascular AMD
This CME monograph, based on an expert roundtable discussion, will present challenging cases in nAMD along with the latest clinical trial data and perspectives on how the newest advances in nAMD treatment can be translated to the real world.
Additional Publications
-
EyePoint Assist: Leave Reimbursement Risk Behind
Sponsored by EyePoint Pharmaceuticals
Dexycu (dexamethasone intraocular suspension) 9% July 2021 Ophthalmic Product Guide
Optimizing OCT Imaging
February 2021 Ophthalmic Product Guide
Durysta: Expand the Way You Care for Patients
Eyepoint Yutiq
